Eskil Elmer - NeuroVive Pharmaceutical Insider

NeuroVive Pharmaceutical AB -- Sweden Stock  

SEK 4.25  0.06  1.43%

Chief Scientific Officer

Mr. Eskil Elmer has served as Chief Scientific Officer at NeuroVive Pharmaceutical AB since 2000. He was Member of the Company Board of Directors from May 2010 until June 8, 2012. Previously, he acted as the Company Chief Executive Officer from 2007 until May 2010, and he also served on the Company Board of Directors between 2000 and 2008. Eskil Elmer is Physician and Associate Professor of experimental neurology. He holds Medical degree and Doctorate of Philosophy degree from Lunds universitet. He is one of the Founders of the Company. He serves as Board member of Maas Biolab LLC and Restorative Neurosurgery Foundation .
Age: 45  Executive Since 2012  Ph.D    
46 4 62 75 62 20  http://www.neurovive.com

Management Efficiency

The company has return on total asset (ROA) of (20.73) % which means that it has lost $20.73 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (54.3) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

NeuroVive Pharmaceutical AB engages in the research, discovery, and development of mitochondrialprotecting pharmaceuticals in Sweden and Hong Kong. NeuroVive Pharmaceutical AB (NVP) is traded on Stockholm Stock Exchange in Sweden. It is located in Lund, and employs 15 people.

Did you try this?

Run Chance of Distress Now
   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
Hide  View All  Next  Launch Chance of Distress
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add NeuroVive Pharmaceutical AB to your portfolio

Top Management

NeuroVive Pharmaceutical Leadership Team
Eskil Elmer, Executive, Ph.D
Carl Olsson, Director
Michele Tavecchio, Executive, Ph.D
David LaskowPooley, Director
Anna Bernsten, Director
Gregory Batcheller, Chairman
Jan Tornell, Director
Marcus Keep, Director
Ingmar Rentzhog, Executive
Catharina Johansson, CFO
Arne Ferstad, Director
Helena Levander, Director
Jan Nilsson, CEO
Erik Kinnman, CEO, MBA
Helmuth Moltke, Director
Magnus Hansson, Executive, Ph.D
Cecilia Hofvander, Director
Boel Flodgren, Director
Eskil MD, Executive
Lars MD, Executive
Christine Tadgell, Executive
David Bejker, Director

Stock Performance

NeuroVive Pharmaceutical Performance Indicators